MA41495A - Composés benzoxaborole et leurs utilisations - Google Patents

Composés benzoxaborole et leurs utilisations

Info

Publication number: MA41495A
Authority: MA; Morocco
Prior art keywords: benzoxaborole compounds; benzoxaborole; compounds
Prior art date: 2015-02-12

Application number

MA041495A

Other languages

English (en)

Inventor

M R K Alley (Dickon)

David Barros-Aguirre

Ilaria Giordano

Vincent Hernandez

Xianfeng Li

Jacob J Plattner

Original Assignee

Anacor Pharmaceuticals Inc

Glaxosmithkline Ip No 2 Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-02-12

Filing date

2016-02-11

Publication date

2017-12-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55409879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41495(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-02-11 Application filed by Anacor Pharmaceuticals Inc, Glaxosmithkline Ip No 2 Ltd filed Critical Anacor Pharmaceuticals Inc

2017-12-19 Publication of MA41495A publication Critical patent/MA41495A/fr

Links

GDMJXXLVTYSBBE-UHFFFAOYSA-N 1,2-benzoxaborole Chemical class C1=CC=C2OB=CC2=C1 GDMJXXLVTYSBBE-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Epidemiology (AREA)
Virology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

MA041495A 2015-02-12 2016-02-11 Composés benzoxaborole et leurs utilisations MA41495A (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP15382056		2015-02-12
EP15382054		2015-02-12
EP15382055		2015-02-12

Publications (1)

Publication Number	Publication Date
MA41495A true MA41495A (fr)	2017-12-19

Family

ID=55409879

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
MA41494A MA41494B1 (fr)	2015-02-12	2016-02-11	Composés benzoxaborole substitués en position 4 et utilisations associées
MA041495A MA41495A (fr)	2015-02-12	2016-02-11	Composés benzoxaborole et leurs utilisations

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
MA41494A MA41494B1 (fr)	2015-02-12	2016-02-11	Composés benzoxaborole substitués en position 4 et utilisations associées

Country Status (36)

Country	Link
US (3)	US20180037595A1 (fr)
EP (2)	EP3256480A1 (fr)
JP (2)	JP6771472B2 (fr)
KR (2)	KR20170117158A (fr)
CN (2)	CN107531730B (fr)
AU (3)	AU2016217508A1 (fr)
BR (2)	BR112017017213A2 (fr)
CA (2)	CA2976308A1 (fr)
CL (2)	CL2017002060A1 (fr)
CO (2)	CO2017008816A2 (fr)
CR (2)	CR20170372A (fr)
CY (1)	CY1123687T1 (fr)
DK (1)	DK3256479T3 (fr)
DO (2)	DOP2017000188A (fr)
EA (2)	EA201791667A1 (fr)
ES (1)	ES2821951T3 (fr)
HR (1)	HRP20201597T1 (fr)
HU (1)	HUE051113T2 (fr)
IL (2)	IL253864B (fr)
LT (1)	LT3256479T (fr)
MA (2)	MA41494B1 (fr)
MX (2)	MX379057B (fr)
MY (1)	MY194004A (fr)
NZ (1)	NZ734379A (fr)
PE (2)	PE20171432A1 (fr)
PH (2)	PH12017501427A1 (fr)
PL (1)	PL3256479T3 (fr)
PT (1)	PT3256479T (fr)
RS (1)	RS60885B1 (fr)
SG (2)	SG11201706510YA (fr)
SI (1)	SI3256479T1 (fr)
SM (1)	SMT202000565T1 (fr)
TW (2)	TWI730953B (fr)
UA (1)	UA120527C2 (fr)
WO (2)	WO2016128949A1 (fr)
ZA (1)	ZA201705456B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP4029870A1 (fr) *	2013-08-09	2022-07-20	GlaxoSmithKline Intellectual Property (No.2) Limited	Composés de benzoxaborole tricyclique et leurs utilisations
PT3621609T (pt)	2017-05-08	2022-08-24	Glaxosmithkline Ip Dev Ltd	Sanfetrinem ou um sal ou um éster do mesmo para a sua utilização no tratamento de infeções micobacterianas
US11834466B2 (en)	2017-11-30	2023-12-05	5Metis, Inc.	Benzoxaborole compounds and formulations thereof
BR112021003037A2 (pt)	2018-08-18	2021-05-11	Boragen, Inc.	formas sólidas de benzoxaborol substituído e composições do mesmo
CN110441344B (zh) *	2019-06-25	2020-09-29	北京大学	一种基于固体核磁共振技术检测rna结构的方法
CN119233823A (zh) *	2022-06-23	2024-12-31	上海盟科药业股份有限公司	硼化合物治疗非结核分枝杆菌感染的方法和用途及用于治疗相同疾病的药物组合物
CA3239097A1 (fr)	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Promedicaments de composes de bore et leur utilisation dans le traitement d'infections bacteriennes
KR20240150582A (ko)	2023-04-08	2024-10-15	김태서	맥세이프 배터리팩을 포함한 아이폰 케이스

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9411587D0 (en) *	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
EP0947498B1 (fr)	1996-12-02	2004-09-15	Chisso Corporation	Derives de nitro-alcool optiquement actifs, derives d'amino-alcool optiquement actifs et procede de leur preparation
EP1567464B1 (fr)	2002-12-02	2007-04-18	Solvias AG	Hydrogenation catalytique de doubles liaisons carbone-heteroatome
US7767657B2 (en)	2005-02-16	2010-08-03	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
SI3424932T1 (sl)	2005-02-16	2021-08-31	Anacor Pharmaceuticals, Inc.	Boronoftalidi za terapevtsko uporabo
WO2006096131A1 (fr)	2005-03-08	2006-09-14	Agency For Science, Technology And Research	Catalyseurs chiraux a base de bisoxazoline
TWM325238U (en) *	2006-12-29	2008-01-11	Universal Scient Ind Co Ltd	Voltage regulator and voltage regulating system
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
CN102256494A (zh)	2008-12-17	2011-11-23	阿纳科制药公司	(s)-3-氨甲基-7-(3-羟基-丙氧基)-3h-苯并[c][1,2]氧杂硼杂环戊-1-醇的多晶型物
WO2011037731A1 (fr) *	2009-09-25	2011-03-31	Anacor Pharmaceuticals, Inc.	Petites molécules contenant du bore
EP2555625B1 (fr) *	2010-04-07	2018-11-14	GlaxoSmithKline LLC	Procédé de préparation de benzoxaboroles
PT3251678T (pt) *	2010-09-07	2021-11-22	Anacor Pharmaceuticals Inc	Derivados de benzoxaborol para tratamento de infeções bacterianas
US8530452B2 (en)	2011-12-22	2013-09-10	Micurx Pharmaceuticals, Inc.	Tricyclic boron compounds for antimicrobial therapy
CN102739587B (zh)	2012-06-16	2014-05-21	天地融科技股份有限公司	音频数据传输方法
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
EP4029870A1 (fr)	2013-08-09	2022-07-20	GlaxoSmithKline Intellectual Property (No.2) Limited	Composés de benzoxaborole tricyclique et leurs utilisations

2016
- 2016-02-11 MA MA41494A patent/MA41494B1/fr unknown
- 2016-02-11 MA MA041495A patent/MA41495A/fr unknown
- 2016-02-12 JP JP2017541999A patent/JP6771472B2/ja active Active
- 2016-02-12 RS RS20201204A patent/RS60885B1/sr unknown
- 2016-02-12 US US15/550,658 patent/US20180037595A1/en not_active Abandoned
- 2016-02-12 DK DK16706002.9T patent/DK3256479T3/da active
- 2016-02-12 CR CR20170372A patent/CR20170372A/es unknown
- 2016-02-12 SG SG11201706510YA patent/SG11201706510YA/en unknown
- 2016-02-12 ES ES16706002T patent/ES2821951T3/es active Active
- 2016-02-12 WO PCT/IB2016/050776 patent/WO2016128949A1/fr not_active Ceased
- 2016-02-12 MX MX2017010413A patent/MX379057B/es unknown
- 2016-02-12 CN CN201680021538.8A patent/CN107531730B/zh active Active
- 2016-02-12 MY MYPI2017702943A patent/MY194004A/en unknown
- 2016-02-12 PE PE2017001400A patent/PE20171432A1/es not_active Application Discontinuation
- 2016-02-12 CA CA2976308A patent/CA2976308A1/fr not_active Abandoned
- 2016-02-12 KR KR1020177025539A patent/KR20170117158A/ko not_active Ceased
- 2016-02-12 US US15/550,693 patent/US10774096B2/en active Active
- 2016-02-12 BR BR112017017213-5A patent/BR112017017213A2/pt not_active Application Discontinuation
- 2016-02-12 CA CA2976030A patent/CA2976030C/fr active Active
- 2016-02-12 BR BR112017017211-9A patent/BR112017017211B1/pt active IP Right Grant
- 2016-02-12 MX MX2017010414A patent/MX2017010414A/es unknown
- 2016-02-12 HU HUE16706002A patent/HUE051113T2/hu unknown
- 2016-02-12 LT LTEP16706002.9T patent/LT3256479T/lt unknown
- 2016-02-12 WO PCT/IB2016/050775 patent/WO2016128948A1/fr not_active Ceased
- 2016-02-12 EP EP16706003.7A patent/EP3256480A1/fr not_active Withdrawn
- 2016-02-12 EA EA201791667A patent/EA201791667A1/ru unknown
- 2016-02-12 JP JP2017542053A patent/JP2018506540A/ja active Pending
- 2016-02-12 AU AU2016217508A patent/AU2016217508A1/en not_active Abandoned
- 2016-02-12 UA UAA201708405A patent/UA120527C2/uk unknown
- 2016-02-12 SG SG11201706511TA patent/SG11201706511TA/en unknown
- 2016-02-12 SM SM20200565T patent/SMT202000565T1/it unknown
- 2016-02-12 PL PL16706002T patent/PL3256479T3/pl unknown
- 2016-02-12 EA EA201791671A patent/EA036516B1/ru unknown
- 2016-02-12 PT PT167060029T patent/PT3256479T/pt unknown
- 2016-02-12 PE PE2017001401A patent/PE20171348A1/es not_active Application Discontinuation
- 2016-02-12 HR HRP20201597TT patent/HRP20201597T1/hr unknown
- 2016-02-12 SI SI201630941T patent/SI3256479T1/sl unknown
- 2016-02-12 EP EP16706002.9A patent/EP3256479B1/fr active Active
- 2016-02-12 KR KR1020177025535A patent/KR20170117156A/ko not_active Withdrawn
- 2016-02-12 AU AU2016217507A patent/AU2016217507B2/en not_active Ceased
- 2016-02-12 CR CR20170371A patent/CR20170371A/es unknown
- 2016-02-12 CN CN201680021488.3A patent/CN107548398A/zh active Pending
- 2016-02-12 NZ NZ734379A patent/NZ734379A/en not_active IP Right Cessation
- 2016-02-15 TW TW105104376A patent/TWI730953B/zh not_active IP Right Cessation
- 2016-02-15 TW TW105104422A patent/TW201702250A/zh unknown
2017
- 2017-08-07 IL IL253864A patent/IL253864B/en unknown
- 2017-08-07 IL IL253865A patent/IL253865A0/en unknown
- 2017-08-09 PH PH12017501427A patent/PH12017501427A1/en unknown
- 2017-08-09 PH PH12017501428A patent/PH12017501428A1/en unknown
- 2017-08-10 DO DO2017000188A patent/DOP2017000188A/es unknown
- 2017-08-10 DO DO2017000189A patent/DOP2017000189A/es unknown
- 2017-08-11 ZA ZA201705456A patent/ZA201705456B/en unknown
- 2017-08-11 CL CL2017002060A patent/CL2017002060A1/es unknown
- 2017-08-11 CL CL2017002059A patent/CL2017002059A1/es unknown
- 2017-08-29 CO CONC2017/0008816A patent/CO2017008816A2/es unknown
- 2017-08-29 CO CONC2017/0008809A patent/CO2017008809A2/es unknown
2020
- 2020-09-11 US US17/018,301 patent/US11214582B2/en not_active Expired - Fee Related
- 2020-10-14 AU AU2020256369A patent/AU2020256369A1/en not_active Abandoned
- 2020-10-15 CY CY20201100978T patent/CY1123687T1/el unknown

Also Published As

Publication number	Publication date
HRP20201597T1 (hr)	2020-12-25
IL253865A0 (en)	2017-10-31
PL3256479T3 (pl)	2021-06-14
JP2018506540A (ja)	2018-03-08
PE20171432A1 (es)	2017-09-26
DK3256479T3 (da)	2020-11-02
US20180037595A1 (en)	2018-02-08
DOP2017000189A (es)	2018-02-15
ES2821951T3 (es)	2021-04-28
EA036516B1 (ru)	2020-11-18
CO2017008809A2 (es)	2017-11-10
MX2017010413A (es)	2018-05-11
UA120527C2 (uk)	2019-12-26
WO2016128948A1 (fr)	2016-08-18
US20210053996A1 (en)	2021-02-25
IL253864B (en)	2021-07-29
EP3256479A1 (fr)	2017-12-20
CL2017002060A1 (es)	2018-03-16
TW201643173A (zh)	2016-12-16
CN107548398A (zh)	2018-01-05
CY1123687T1 (el)	2022-03-24
HUE051113T2 (hu)	2021-01-28
CN107531730A (zh)	2018-01-02
AU2020256369A1 (en)	2020-11-12
CA2976030A1 (fr)	2016-08-18
EA201791671A1 (ru)	2018-02-28
AU2016217508A1 (en)	2017-09-28
BR112017017211A2 (pt)	2018-04-03
CA2976308A1 (fr)	2016-08-18
CL2017002059A1 (es)	2018-03-16
CA2976030C (fr)	2023-09-26
KR20170117158A (ko)	2017-10-20
PH12017501428A1 (en)	2018-01-15
CR20170371A (es)	2018-01-22
US11214582B2 (en)	2022-01-04
AU2016217507A1 (en)	2017-09-28
US10774096B2 (en)	2020-09-15
AU2016217507B2 (en)	2019-03-14
CR20170372A (es)	2017-10-19
MA41494A (fr)	2017-12-19
EA201791667A1 (ru)	2018-02-28
CN107531730B (zh)	2020-08-07
LT3256479T (lt)	2020-12-28
KR20170117156A (ko)	2017-10-20
EP3256480A1 (fr)	2017-12-20
IL253864A0 (en)	2017-09-28
PH12017501427A1 (en)	2018-01-15
MY194004A (en)	2022-11-07
PE20171348A1 (es)	2017-09-13
MA41494B1 (fr)	2020-10-28
JP2018506538A (ja)	2018-03-08
ZA201705456B (en)	2019-10-30
WO2016128949A1 (fr)	2016-08-18
MX2017010414A (es)	2018-05-11
JP6771472B2 (ja)	2020-10-21
SMT202000565T1 (it)	2020-11-10
TW201702250A (zh)	2017-01-16
EP3256479B1 (fr)	2020-07-29
DOP2017000188A (es)	2017-09-15
SG11201706511TA (en)	2017-09-28
BR112017017211B1 (pt)	2023-04-25
NZ734379A (en)	2023-06-30
MX379057B (es)	2025-03-10
PT3256479T (pt)	2020-10-22
SI3256479T1 (sl)	2020-11-30
BR112017017213A2 (pt)	2018-04-03
SG11201706510YA (en)	2017-09-28
CO2017008816A2 (es)	2017-11-10
TWI730953B (zh)	2021-06-21
RS60885B1 (sr)	2020-11-30
US20180044353A1 (en)	2018-02-15

Publication	Publication Date	Title
MA50256A (fr)	2020-07-22	Composés de pyrazolopyrimidinone et leurs utilisations
EP3337486A4 (fr)	2019-03-06	Composés deutérés et leurs utilisations
EP3694861A4 (fr)	2021-05-19	Composés hétérocycliques et leurs utilisations
MA43205A (fr)	2018-09-19	Composés pyy sélectifs et leurs utilisations
MA50618A (fr)	2020-08-12	Polyrhérapies et leurs utilisations
MA41598A (fr)	2018-01-02	Composés thérapeutiques de pyridazine et leurs utilisations
EP3352776A4 (fr)	2019-03-13	Répresseurs htt et leurs utilisations
EP3389658A4 (fr)	2019-07-10	Inhibiteurs de glycosidase et leurs utilisations
EP3328199A4 (fr)	2019-02-27	Compositions antimicrobiennes et leurs utilisations
EP3349802A4 (fr)	2019-03-20	Dendrimères lipocationiques et leurs utilisations
EP2970307A4 (fr)	2016-10-05	Composés pyrazolo et leurs utilisations
EP3334706A4 (fr)	2019-03-13	Pillararènes et utilisations de ceux-ci
MA52365A (fr)	2021-03-03	Composés et leurs utilisations
EP2951177A4 (fr)	2016-06-01	Composés imidazopyridine et leurs utilisations
EP2991978A4 (fr)	2016-09-14	Composés bihétéroaryle et leurs utilisations
EP3768269A4 (fr)	2022-03-23	Composés et leurs utilisations
EP3370528A4 (fr)	2019-05-01	Compositions probiotiques et leurs utilisations
MA43567A (fr)	2018-11-14	Anticorps pacap et leurs utilisations
EP3347021A4 (fr)	2019-07-24	Cyano-thiénotriazoloazépines et leurs utilisations
EP3494119A4 (fr)	2020-03-25	Composés et compositions, et utilisations associées
EP3538261A4 (fr)	2020-06-10	Catalyseurs en pérovskite et leurs utilisations
EP3347020A4 (fr)	2019-08-14	Acétamide thiénotriazoldiazépines et leurs utilisations
EP2958895A4 (fr)	2016-10-26	Composés thérapeutiques et leurs utilisations
EP3450444A4 (fr)	2019-05-01	Composés de type crocine et utilisations correspondantes
MA41495A (fr)	2017-12-19	Composés benzoxaborole et leurs utilisations